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Abstract
Mycobacterium tuberculosis uses multiple mechanisms to avoid elimination by the immune system. We have previously
shown that M. tuberculosis can inhibit selected macrophage responses to IFN-c through TLR2-dependent and -independent
mechanisms. To specifically address the role of TLR2 signaling in mediating this inhibition, we stimulated macrophages with
the specific TLR2/1 ligand Pam3CSK4 and assayed responses to IFN-c. Pam3CSK4 stimulation prior to IFN-c inhibited
transcription of the unrelated IFN-c-inducible genes, CIITA and CXCL11. Surface expression of MHC class II and secretion of
CXCL11 were greatly reduced as well, indicating that the reduction in transcripts had downstream effects. Inhibition of both
genes required new protein synthesis. Using chromatin immunoprecipitation, we found that TLR2 stimulation inhibited IFN-
c-induced RNA polymerase II binding to the CIITA and CXCL11 promoters. Furthermore, TATA binding protein was unable
to bind the TATA box of the CXCL11 promoter, suggesting that assembly of transcriptional machinery was disrupted.
However, TLR2 stimulation affected chromatin modifications differently at each of the inhibited promoters. Histone H3 and
H4 acetylation was reduced at the CIITA promoter but unaffected at the CXCL11 promoter. In addition, NF-kB signaling was
required for inhibition of CXCL11 transcription, but not for inhibition of CIITA. Taken together, these results indicate that
TLR2-dependent inhibition of IFN-c-induced gene expression is mediated by distinct, gene-specific mechanisms that disrupt
binding of the transcriptional machinery to the promoters.
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Introduction
Macrophages are important mediator cells during the immune
response to invading pathogens. They are able to recognize a
variety of pathogens through cell surface receptors, including
members of the Toll-like receptor (TLR) family [1]. Among these
receptors, TLR2 and TLR4 specifically recognize bacteria-
derived lipopeptides and LPS, respectively. Engagement of TLRs
results in activation of MAPK and NF-kB signaling pathways,
culminating in the expression of proinflammatory cytokines and
antimicrobial effector molecules [2,3], as well as in the induction of
apoptosis [4].
Macrophages also function as effector cells in the adaptive
immune response. While macrophages play an important part in
controlling infections as part of the innate immune response, full
activation of their antimicrobial capacity and antigen presentation
function only occurs after stimulation with the Th1 cytokine IFN-c
[5]. IFN-c is essential for the control of Mycobacterium tuberculosis [6–
9] and the clearance of other intracellular pathogens [10–13].
IFN-c acts by binding to the heterodimeric IFN-c receptor.
Receptor binding and dimerization leads to the recruitment of
JAKs 1 and 2 and ultimately to tyrosine and serine phosphory-
lation of the transcription factor STAT1 [14]. Phospho-STAT1
dimers then drive gene expression by binding gamma-activated
sites (GAS) in the promoters of a large number of genes.
While exposure to a TLR agonist and IFN-c can have
synergistic effects and enhance activation of some IFN-c-induced
genes [15], a number of studies have shown that LPS [16,17],
whole mycobacteria [18–22], the mycobacterial lipoglycan
phosphatidylinositol mannan [23], and mycobacterial lipoproteins
[24,25] can have inhibitory effects on a subset of IFN-c-induced
genes. This appears to be of special relevance in the context of
infections with M. tuberculosis where, even in the presence of a
strong adaptive immune response, clearance of bacteria from the
infected tissue is not achieved [6,26,27].
Although inhibition of IFN-c-induced gene expression by M.
tuberculosis occurs by both TLR2-dependent and -independent
mechanisms in vitro [24] and in vivo [28], we focused on the
contribution of TLR2 signaling to inhibition in the experiments
reported here. Pam3CSK4, a synthetic triacylated hexapeptide and
specific TLR2/1 ligand [29], has been found to mimic the
inhibitory effects of mycobacterial lipoproteins in macrophages
[23]. Inhibition of class II transactivator (CIITA), a gene required
for antigen presentation via MHC class II to CD4
+ T cells [30],
has been well characterized [18,20,24,25,31]. We wanted to
extend these findings and compare inhibition of CIITA with that
of CXCL11, another IFN-c-inducible gene that we found to be
strongly inhibited by Pam3CSK4 through microarray analysis.
CXCL11 is a member of the CXC chemokine family and ligand
for CXCR3, which is expressed on activated CD4
+ T cells [32].
PLoS ONE | www.plosone.org 1 July 2009 | Volume 4 | Issue 7 | e6329CXCL11 acts as a chemoattractant to recruit these cells to the site
of inflammation [33]. Although studied during chronic M.
tuberculosis infection [34], the role of CXCL11 during early
infection is unknown.
We found that TLR2 inhibition of IFN-c-induced transcription
of CXCL11 and CIITA required new protein synthesis, but that
inhibition of each of these genes involved distinct downstream
mechanisms.
Materials and Methods
Reagents and antibodies
(S)-[2,3,-Bis(palmitoyloxy)-(2-RS)-propyl]-N-palmitoyl-(R)-Cys-
(S)-Ser-(S)-Lys4-OH, 3HCl (Pam3CSK4; Calbiochem) was stored
at 1 mg/ml in endotoxin-tested water (Invitrogen Life Technol-
ogies). Cycloheximide (Calbiochem) was stored at 100 mg/ml
(355 mM) in DMSO. Recombinant murine IFN-c was purchased
from BD Biosciences. Polyclonal anti-acetyl-histone H3 and H4
antibodies were from Millipore. Antibodies for RNA polymerase
II (N-20) and TFIID (TBP) (N-12) were purchased from Santa
Cruz Biotechnology.
Mice
C57BL/6 mice were purchased from The Jackson Laboratory,
BALB/c mice were purchased from Taconic, and TNFkB
(TNF
2/2/RelA
+/2) mice were purchased from Riken. All were
maintained under specific pathogen-free conditions. All work with
animals was approved by the New York University School of
Medicine Institutional Animal Care and Use Committee.
Isolation and culture of bone marrow-derived
macrophages
Bone marrow-derived macrophages (BMDM) were isolated and
cultured as previously described [23]. All experiments were done
with C57BL/6 BMDM unless otherwise specified.
RNA harvest and quantitative real-time PCR (qPCR)
BMDM from BALB/c mice (2610
6) were incubated with
Pam3CSK4 (10 ng/ml) for 8 h followed by IFN-c (20 ng/ml) for
4, 8, and 12 h. For cycloheximide experiments, BMDM from
C57BL/6 mice were pretreated with DMSO or cycloheximide
(500 nM) for 1 h, followed by Pam3CSK4 (10 ng/ml) for 8 h
followed by IFN-c (20 ng/ml) for 4 h in the continued absence or
presence of the inhibitor. For examining NF-kB, BMDM from
TNF
2/2/RelA
+/+ and TNF
2/2/RelA
2/2 mice were treated
with Pam3CSK4 (10 ng/ml) for 8 h followed by IFN-c (20 ng/ml)
for 4 h. Total RNA was harvested using Qiagen RNeasy columns
according to the manufacturer’s directions. Genomic DNA
contamination was removed by DNase treatment (Ambion). Total
RNA yield was determined by nanodrop quantitation and 1 mg
was reverse transcribed using the Reverse Transcription System
(Promega). The cDNA equivalent of 10 ng (for GAPDH) or 50 ng
(for CXCL11, CIITA, and NOS2) of total RNA was analyzed by
quantitative PCR using FastStart Universal SYBR Green Master
Mix (Roche) on an MJ Research Opticon 2. For quantitation, the
relative values were determined by comparing the threshold cycle
of each sample to a standard curve consisting of serial dilutions of a
positive control cDNA sample and normalized to GAPDH. The
following primers were used: CXCL11 sense, 59-GCA CCT CTT
TCA GTC TGT TTC CTG-39; CXCL11 antisense, 59-AGC
CAT CCC TAC CAT TCA TTC AC-39; CIITA pIV sense, 59-
GAA GTT CAC CAT TGA GCC ATT TAA-39; CIITA pIV
antisense, 59-CTG GGT CTG CAC GAG ACG AT-39; NOS2
sense, 59-GTT CTC AGC CCA ACA ATA CAA GA-39; NOS2
antisense, 59-GTG GAC GGG TCG ATG TCA C-39; GAPDH
sense, 59-TGT GTC CGT CGT GGA TCT GA-39; GAPDH
antisense, 59-CCT GCT TCA CCA CCT TCT TGA-39.
Flow cytometry
Macrophages (2610
6) were plated on non-tissue culture treated
plates and treated with Pam3CSK4 (10 ng/ml) for 12–15 h,
followed by IFN-c (20 ng/ml) for 24 h. Cells were harvested from
plates by incubation in PBS containing 5 mM EDTA for 20 min
at 4uC, then vigorous pipetting. Cells were stained with Alexa 647-
conjugated anti-mouse I-A/I-E (Biolegend), washed, and resus-
pended in ice-cold FACS buffer (PBS, 0.1% sodium azide, 1%
FCS, 500 mM EDTA). Cells were analyzed for MHC class II
surface expression using a FACSCalibur (30,000 total events gated
by forward and side scatter; BD Biosciences).
ELISA
Since the CXCL11 gene in C57BL/6 mice contains a point
mutation that results in the lack of CXCL11 secretion [35], BMDM
from BALB/c mice were treated with Pam3CSK4 (10 ng/ml) for
8 h, followed by IFN-c (20 ng/ml) for 4, 8, and 12 h. Culture
supernatants were harvested and assayed for murine CXCL11 by
ELISA according to the manufacturer’s directions (R & D Systems).
Samples were used neat or diluted 1:10 or 1:50 to allow detection
within the range of the assay. Results were quantitated using an
ELx800UV spectrophotometer (Bio-Tek Instruments).
Chromatin immunoprecipitation (ChIP)
8210610
6 macrophages were treated with Pam3CSK4 (10 ng/
ml) for 8–9 h, followed by IFN-c (20 ng/ml) for 4, 8, and 12 h (for
PolII and TBP binding) or 1, 2, 4, and 8 h (for histone acetylation).
Cells were crosslinked by adding 1% formaldehyde for 10 min at
37uC, followed by addition of glycine (125 mM) for 5 min at room
temperature.Cells were washedtwice with ice-cold PBS andscraped
in PBS containing protease inhibitors (Complete Mini, Roche).
Fixed cells were pelleted and snap-frozen in liquid nitrogen. Samples
were processed using the ChIP assay kit from Millipore (17–295).
Cell pellets were thawed, resuspended in SDS lysis buffer, and lysed
on ice for 10 min. Chromatin was fragmented using a Branson
Digital Sonifier 250 (6 rounds at 20% amplitude for 40 s each round
(0.5 s pulse, 1 s break)). One-third of the fragmented chromatin was
diluted five-fold in ChIP dilution buffer. 1% of each sample was set
aside as input DNA. Chromatin was immunoprecipitated overnight
with anti-RNA polymerase II (10 mg), anti-TFIID (10 mg), or anti-
acetylated histone H3 (5 mg) or H4 (4 mg) antibodies; the specificity
of binding was determined using controls in which the primary
antibody was omitted. Chromatin-antibody complexes were cap-
tured by incubation with protein A agarose beads for 1 h at 4uC,
then chromatin-antibody-bead complexes were washed for 5 min at
4uC with 1 ml of each buffer in the following order: low salt immune
complex wash buffer, high salt immune complex wash buffer, LiCl
immune complex wash buffer, and TE (as described in the
manufacturer’s protocol). Chromatin was released from the beads
with elution buffer (1% SDS, 0.1 M NaHCO3), and crosslinking was
reversed by incubating input and sample chromatin in 0.2 M NaCl
for 4 h at 65uC. Sample chromatin was incubated with proteinase K
for 1 h at 45uC and ethanol-precipitated, then sample and input
chromatin were diluted five-fold in PB buffer and purified with
QiaQuick columns according to the manufacturer’s protocol
(Qiagen). Purified sample and input DNA was eluted with 50 ml
EB buffer. 2.5 ml of eluted DNA were assayed by qPCR using
primers specific for the promoter region of the assayed gene and
genomic DNA as standard. ChIP output was normalized to the
amount of input DNA. The resulting values for each gene were
Inhibition of Transcription
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enrichment is expressed in relation to the value determined for the
untreated sample value. The primers used are listed in Table 1.
Results
TLR2 stimulation inhibits IFN-c-induced transcription of
CXCL11 and CIITA, but not NOS2
In the context of initial infection with M. tuberculosis, lung
macrophages are likely to encounter the bacteria before being
stimulated by IFN-c. Therefore, we studied the effects of TLR2
stimulation by Pam3CSK4 prior to stimulation of macrophages with
IFN-c. We first analyzed the kinetics of TLR2-initiated inhibition of
IFN-c induction of CXCL11 and CIITA. Bone marrow-derived
macrophages (BMDM) were treated with Pam3CSK4 for 8 h then
stimulated with IFN-c for 4, 8, and 12 h. Although CIITA and
CXCL11 were both induced by IFN-c, the kinetics of their
induction differed. CXCL11 mRNA levels peaked after 4 h of IFN-
c stimulation whereas CIITA mRNA peaked after 12 h (Figs. 1A
and B). Transcription of both CXCL11 and CIITA was fully
inhibited in cells previously exposedto Pam3CSK4, regardless of the
length of IFN-c stimulation. As a control, we examined transcrip-
tion of NOS2, an IFN-c-inducible gene that has been found not to
be inhibited by M. tuberculosis or mycobacterial lipoproteins [21,24].
We found that Pam3CSK4 treatment prior to IFN-c stimulation
enhanced transcription of NOS2 in macrophages (Fig. 1C). These
data show that TLR2 stimulation affects IFN-c-induced transcrip-
tion in a gene-specific manner.
TLR2 stimulation inhibits CXCL11 protein production and
MHC class II surface expression
Since transcription of CXCL11 and CIITA was significantly
reduced in TLR2 stimulated macrophages, we determined
whether inhibition was reflected by reduction of the protein
products of these genes. To examine the effect on CXCL11, we
treated BALB/c BMDM with Pam3CSK4 for 8 h followed by
IFN-c for 4, 8, and 12 h. Culture supernatants were harvested and
assayed for CXCL11 by ELISA. Stimulation with IFN-c resulted
in secretion of CXCL11 after 8 and 12 h of treatment (Fig. 2A).
However, prior TLR2 stimulation inhibited IFN-c-induced
CXCL11 protein levels by over 80% at both of these time points.
To examine the downstream effect of TLR2 stimulation on
CIITA, we measured surface expression of MHC class II, whose
expression is regulated by, and depends on, CIITA. BMDM were
treated with Pam3CSK4 for 12–15 h then stimulated with IFN-c
for 24 h (the minimal time needed for increased MHC class II
surface expression). IFN-c stimulation alone caused an eleven-fold
increase of MHC class II on the cell surface (Fig. 2B). However,
Pam3CSK4 treatment prior to IFN-c inhibited this upregulation
by 73%, as assessed by mean fluorescent intensity (Fig. 2C).
Pam3CSK4 alone (without IFN-c) had no effect on surface MHC
class II levels. These results indicate that TLR2-mediated
inhibition of CXCL11 and CIITA transcription has downstream
consequences at the protein level.
TLR2-mediated inhibition of CXCL11 and CIITA requires
new protein synthesis
We have previously shown that M. tuberculosis-mediated
inhibition of CIITA induction by IFN-c requires new protein
synthesis [23]. We extended these findings and examined the effect
of cycloheximide, a pharmacological inhibitor of protein synthesis,
on induction of CXCL11, CIITA, and NOS2 mRNA by IFN-c in
TLR2 stimulated macrophages. In control samples, TLR2
stimulation prior to IFN-c inhibited CXCL11 and CIITA
induction, but enhanced NOS2 induction, as previously seen.
However, treatment with cycloheximide fully reversed inhibition
of CXCL11 and CIITA and further enhanced NOS2 expression
(Fig. 3). These results indicate that TLR2 stimulation induces
production of one or more proteins that are required for inhibition
of macrophage gene expression in response to IFN-c. Cyclohex-
imide treatment also greatly enhanced expression of all three
genes, with the strongest effect on CXCL11, presumably due to
the lack of a negative regulatory protein.
TLR2 stimulation prevents RNA polymerase II from
binding the CXCL11 and CIITA promoters
To further characterize the mechanism of inhibition of
transcriptional responses to IFN-c by prior TLR2 stimulation, we
determinedwhetherRNApolymerase II(PolII) bindsthepromoters
of the affected genes. We treated BMDM with Pam3CSK4 for 8 h
then stimulated with IFN-c for 4 h, followed by chromatin
immunoprecipitation (ChIP) to assay binding of PolII to the
CXCL11, CIITA, and NOS2 promoters. Primers that specifically
amplified regions flanking the transcriptional start site of each gene
were designed to detect initial binding of PolII to the promoters.
IFN-c stimulation induced binding of PolII to the CXCL11 and
CIITA promoters, as indicated by a three-fold increase in pulldown
of promoter fragments of these genes (Fig. 4A). However,
stimulation of TLR2 prior to IFN-c inhibited binding of PolII by
66% (CXCL11) and 76% (CIITA) compared with IFN-c alone.
The effect of TLR2 stimulation was not merely to delay IFN-c-
stimulated PolII binding at these promoters, as similar inhibition of
binding was seen after 8 and 12 h of IFN-c stimulation (data not
shown). As a control, we assayed PolII binding at the NOS2
promoter, since TLR2 stimulation did not decrease NOS2 mRNA
induction by IFN-c (Fig. 1C).IFN-c stimulationalone causeda two-
fold increase in binding and prior Pam3CSK4 treatment resulted in
a further increase in binding (Fig. 4A). This was similar to the effect
Table 1. Primers used for ChIPs.
Primer name Sequence (59 to 39)
CXCL11_HISF TCT GCC CAG AAT CCC TAC AC
CXCL11_HISR AGA AGC CAC TGG AAG GTG AA
GAPDH_HISF GGT CCA AAG AGA GGG AGG AG
GAPDH_HISR AGC TAC GTG CAC CCG TAA AG
CIITA_HISF AGC AAA CTT GGG TTG CAT GT
CIITA_HISR TCC TGG CAG CTA TCT CAC AA
NOS2_HISF CAC TAT TCT GCC CAA GCT GAC TTA C
NOS2_HISR CAA TAT TCC AAC ACG CCC AGG
CXCL11_POLF ACT GCC TGA AGA TTG CTG GT
CXCL11_POLR ATA TTG CAG CCA GGG CTA TG
GAPDH_POLF CCG CAT CTT CTT GTG CAG T
GAPDH_POLR TCC CTA GAC CCG TAC AGT GC
CIITA_POLF GAT AGC TGC CAG GAG ACT GC
CIITA_POLR CAA ACG GGA TCT TGG AGA CA
NOS2_POLF CCC TTT GGG AAC AGT TAT GC
NOS2_POLR CCA AGG TGG CTG AGA AGT TT
CXCL11_TBPF GCT GAG TGC TTT CAC CTT CC
CXCL11_TBPR GGC TGA ACC TGA GGA GTC TG
doi:10.1371/journal.pone.0006329.t001
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that TLR2 stimulation prevents PolII from binding to the CXCL11
and CIITA promoters, but does not affect binding to the NOS2
promoter. The effect of TLR2 stimulation on transcription of IFN-
c-responsive genes correlates with PolII binding at the respective
promoters.
TLR2 stimulation prevents binding of TBP to the CXCL11
promoter
Since we found that TLR2 stimulation prevents PolII from
binding the CXCL11 and CIITA promoters, we determined
whether another member of the general transcriptional machinery
was similarly affected. We examined the ability of TATA binding
Figure 1. TLR2 stimulation inhibits IFN-c-induced transcription of a subset of genes. BALB/c BMDM were treated with 10 ng/ml Pam3CSK4
for 8 h, and then 20 ng/ml IFN-c for 4, 8, and 12 h. Total RNA was harvested, reverse transcribed, and CXCL11 (A), CIITA (B), and NOS2 (C) expression
analyzed by quantitative real-time PCR (qPCR). All values were normalized to GAPDH. Results are shown as fold induction compared to untreated
sample without Pam3CSK4 or IFN-c.* ,p ,0.01, **, p,0.05 comparing IFN-c alone samples with those treated with Pam3CSK4 prior to IFN-c (as
determined by two-tailed t test). Results in (A) are expressed as means6SEM of three independent experiments. Results in (B) and (C) are
representative of three independent experiments. Similar results were obtained with C57BL/6 BMDM.
doi:10.1371/journal.pone.0006329.g001
Figure 2. TLR2-mediated inhibition of IFN-c induction of CXCL11 and CIITA decreases expression of protein products. A. BALB/c
BMDM were treated with 10 ng/ml Pam3CSK4 for 8 h followed by 20 ng/ml IFN-c for 4, 8, and 12 h. Culture supernatants were collected and assayed
for CXCL11 protein by ELISA. *, p,0.01, **, p,0.05 comparing IFN-c alone with Pam3CSK4 and IFN-c treated samples (as determined by two-tailed t-
test). B and C. BMDM were treated with 10 ng/ml Pam3CSK4 for 12–15 h prior to stimulation with 20 ng/ml IFN-c for 24 h. Cells were stained with
Alexa 647-conjugated anti-mouse I-A/I-E and analyzed by flow cytometry. Data shown are fluorescence intensity vs. cell number (B) and mean I-A/I-E
fluorescence (C). Results are expressed as means6SEM from two independent experiments (A) and are representative of at least five independent
experiments (B and C).
doi:10.1371/journal.pone.0006329.g002
Inhibition of Transcription
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following Pam3CSK4 and IFN-c stimulation. The CIITA
promoter lacks a TATA box (our unpublished observation), so
we did not include it in our experiments. IFN-c stimulation
resulted in a five to seven-fold increase in TBP binding to the
CXCL11 promoter after 4, 8, and 12 h (Fig. 4B and data not
shown). However, TLR2 stimulation prior to IFN-c decreased
TBP binding to the CXCL11 promoter by 65%. This suggests that
the lack of transcription is not due to a deficiency in PolII binding
alone, but that prolonged TLR2 signaling also inhibits binding of
other members of the general transcriptional machinery.
TLR2 signaling inhibits histone acetylation at the CIITA
promoter, but not at the CXCL11 promoter
Transcriptional activity is usually associated with increased
acetylation of histones H3 and H4 in the promoter region of
transcribed genes [36], and TLR2 stimulation by the mycobacterial
lipoprotein LpqH inhibits acetylation of histones H3 and H4 at the
CIITA promoter after 4 h of IFN-c stimulation in macrophages [25].
We extended these findings by examining earlier IFN-c time points
and by determining whether TLR2 stimulation also inhibited histone
acetylation at the CXCL11 promoter. BMDM were treated with
Pam3CSK4 for 8 h followed by IFN-c f o r1 ,2 ,4 ,a n d8h .C h I P s
were then performed using antibodies against either acetylated
histone H3 or acetylated histone H4. At the CXCL11 promoter, we
observed a rapid increase in acetylation of both histones after 1 h of
IFN-c stimulation, which persisted for as long as IFN-c was present
(Figs. 5A and D). TLR2 stimulation prior to IFN-c did not inhibit
histone acetylation at the CXCL11 promoter at any time point after
IFN-c stimulation. In contrast, TLR2 stimulation significantly
inhibited histone H3 and H4 acetylation at the CIITA promoter
by 35–63% at all IFN-ctimepoints(Figs.5B and E).Forcomparison,
we also examined histone acetylation at the NOS2 promoter. TLR2
stimulation prior to IFN-c resulted in an increase of histone
acetylation over IFN-c stimulation alone (Figs. 5C and F). These
data indicate that TLR2-mediated inhibition of IFN-c induction of
CIITA and CXCL11 occurs by at least two distinct mechanisms, one
that affects histone acetylation and one that does not.
NF-kB is required for TLR2-mediated inhibition of
CXCL11, but not CIITA, transcription
Transcriptional responses to TLR2 activation are largely
mediated by the transcription factor NF-kB, a heterodimer
Figure 3. New protein synthesis is required for inhibition of CIITA and CXCL11. BMDM were pretreated with 500 nM cycloheximide or DMSO
for 1 h prior to treatment with 10 ng/ml Pam3CSK4 for 8 h followed by 20 ng/ml IFN-c for 4 h in the continued presence or absence of inhibitor. Total
RNAwasharvestedafterIFN-cstimulation.CXCL11(A),CIITA(B),andNOS2(C)expressionwasassayedbyqPCRandnormalizedtoGAPDHanduntreated
samples. The concentration of cycloheximide used inhibited TNF production (as a measure of protein synthesis) by over 90% with minimal cell death.
Statistical significance between IFN-c alone samples and those treated with Pam3CSK4 prior to IFNc was determined by two-tailed t-test.
doi:10.1371/journal.pone.0006329.g003
Figure 4. TLR2 stimulation prevents binding of general
transcriptional machinery to the CIITA and CXCL11 promoters.
BMDM were treated with 10 ng/ml Pam3CSK4 for 8–9 h, then 20 ng/ml
IFN-c for 4 h. Cross-linked DNA was sheared and immunoprecipitated
with anti-PolII (A) or anti-TBP (B) antibodies. Precipitated and input DNA
for each sample were assayed by qPCR with primers specific for the
transcriptional start site in the promoters of CXCL11, CIITA, and NOS2
(A) or the TATA box of the CXCL11 promoter (B). All values were
normalized to GAPDH. Results are expressed as fold increase over
untreated controls and are the mean of triplicate samples6SD.
Statistical significance between IFN-c alone samples and Pam3CSK4
prior to IFN-c treated samples was determined by two-tailed t-test.
Results are representative of at least two independent experiments.
doi:10.1371/journal.pone.0006329.g004
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deficiency is embryonic lethal but can be rescued by deletion of
TNF [37,38]. We examined the role of NF-kB in TLR2-mediated
inhibition of responses to IFN-c using macrophages from TNF
2/
2/RelA
2/2 and TNF
2/2/RelA
+/+ mice. BMDM were treated
with Pam3CSK4 for 8 h followed by IFN-c for 4 h. TLR2
stimulation prior to IFN-c inhibited induction of CXCL11 and
CIITA in RelA
+/+ macrophages (Figs. 6A and B). In RelA
2/2
macrophages, CXCL11 induction by IFN-c was fully restored
despite prior TLR2 stimulation (Fig. 6A). However, CIITA
induction was still significantly reduced in these cells (Fig. 6B).
TNF deficiency did not affect transcriptional responses of
CXCL11 or CIITA, as results with TNF
2/2/RelA
+/+ macro-
phages were similar to C57BL/6 macrophages (data not shown).
However, lack of TNF did result in lower NOS2 expression that
was further decreased in RelA
2/2 macrophages (Fig. 6C). These
data provide further support that CXCL11 and CIITA are
differentially regulated upon TLR2 stimulation. Inhibition of
CXCL11 induction requires NF-kB whereas inhibition of CIITA
does not.
Figure 5. TLR2 stimulation inhibits histone acetylation at the CIITA promoter, but not the CXCL11 promoter. BMDM were treated with
10 ng/ml Pam3CSK4 for 8 h prior to stimulation with 20 ng/ml IFN-c for 1, 2, 4, and 8 h. Cross-linked, sheared DNA was immunoprecipitated with
antibodies against either acetylated histone H3 (A, B, C) or H4 (D, E, F). Precipitates were analyzed by qPCR using primers specific for the CXCL11 (A,
D), CIITA (B, E), and NOS2 (C, F) promoters. Values were normalized to GAPDH and untreated controls and are the mean of triplicate samples6SD. *,
p,0.01 comparing IFN-c alone with Pam3CSK4 prior to IFN-c treated samples (as determined by two-tailed t-test). Results are representative of two
independent experiments.
doi:10.1371/journal.pone.0006329.g005
Figure 6. IFN-c-induced transcription of CXCL11, but not CIITA, is restored in TLR2 stimulated RelA
2/2 macrophages. BMDM from
TNF
2/2/RelA
+/+ and TNF
2/2/RelA
2/2 mice were treated with 10 ng/ml Pam3CSK4 for 8 h followed by 20 ng/ml IFN-c for 4 h. Total RNA was
harvested, reverse transcribed, and CXCL11 (A), CIITA (B), and NOS2 (C) expression analyzed by qPCR. All values were normalized to GAPDH and
shown as fold induction compared to untreated samples without Pam3CSK4 or IFN-c. Statistical significance was determined by two-tailed t-test
between IFN-c alone with Pam3CSK4 prior to IFN-c samples. C57BL/6 BMDM showed similar results to those obtained with TNF
2/2/RelA
+/+ BMDM.
doi:10.1371/journal.pone.0006329.g006
Inhibition of Transcription
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M. tuberculosis survives in macrophages, even when they are
stimulated with IFN-c [39,40]. We and others have found that M.
tuberculosis blocks selected macrophage responses to IFN-c by
inhibiting transcription of a subset of IFN-c-inducible genes
[18,20–22]. At least two proximal mechanisms are involved. One
is initiated by mycobacterial peptidoglycan in a TLR2- and
MyD88-independent manner [24], while the other requires TLR2
and MyD88 and is initiated by lipoproteins and phosphatidylino-
sitol mannan [23,24]. In the experiments presented here, we
examined the mechanisms downstream of TLR2 in mediating this
inhibition, by using the specific TLR2/1 agonist Pam3CSK4.
This work expands on previous studies that examined inhibition
of CIITA transcription [18,20,24,25,31], by comparing the
kinetics of inhibition of CIITA with that of CXCL11, an unrelated
IFN-c-inducible gene, as well as with NOS2, an IFN-c-inducible
gene that is not inhibited by M. tuberculosis [21,24]. We found that
TLR2 stimulation inhibited IFN-c-induced transcription of
CIITA and CXCL11 to similar levels over a time course of
IFN-c stimulation (Figs. 1A and B), indicating that macrophages
are unable to recover the ability to respond to IFN-c, regardless of
the length of stimulation. This reduction in transcription resulted
in decreased CXCL11 secretion and decreased MHC class II on
the macrophage surface (Fig. 2). However, TLR2 stimulation
resulted in an increase in NOS2 mRNA (Fig. 1C), indicating that
TLR2-mediated transcriptional inhibition is gene specific, and
therefore not mediated by inhibition of a proximal signaling step
such as STAT1 activation.
One of the initial steps in transcription initiation is acetylation of
lysine residues within the N-terminal tails of core histones. This
decreases their affinity for DNA, allowing a more permissive
chromatin structure for transcription factors and other proteins to
bind to DNA [41]. This process is tightly controlled by two
counteracting enzymatic activities: the histone deacetylases
(HDACs) and the histone acetyltransferases (HATs). HDACs
repress transcription by removing acetyl groups whereas HATs
acetylate critical lysines.
Mammalian HDACs fall into three classes (I, II, and III) based
on sequence homology to yeast HDACs [42]. Class II and III
HDACs are expressed in a limited number of tissues. However,
HDACs 1 and 2 (of class I) appear to be constitutively expressed
[43–47]. Therefore, their activity must be tightly regulated. They
are the enzymatically active components of multi-protein com-
plexes, which include DNA binding proteins and corepressors.
These complexes target the HDACs to the promoters of genes by
interactions with sequence-specific transcription factors, leading to
transcriptional repression of select genes. HDACs require complex
formation for enzymatic activity, as most purified recombinant
HDACs are inactive [48,49]. In addition to regulation by protein-
protein interactions, HDACs can be post-translationally modified.
Casein kinase 2 (CK2), a ubiquitously expressed protein kinase,
has been identified as a key regulator of class I HDACs [50,51].
CK2 activity is induced by a number of stimuli including IFN-c
and the TLR4 ligand LPS [52]. CK2 phosphorylation of S421/
S422 and S423/S424 at the C-terminal region of HDACs 1 and 2,
respectively, is important for complex formation and enzymatic
activity. Although more light is being shed on how HDAC activity
is regulated, many of the signaling pathways involved remain to be
elucidated.
HATs are a diverse group of enzymes that regulate transcription
by rendering the chromatin more accessible via acetylation of
histone tails. Gene transcription in response to IFN-c involves
CREB binding protein (CBP) and/or p300, coactivators that have
HAT activity [53]. Following IFN-c stimulation, phosphorylated
STAT1 associates with CBP/p300, which is thought to facilitate
contact with transcriptional machinery at the promoter regions of
IFN-c-inducible genes [54]. Similar to HDACs, the HAT activity
of CBP and p300 is tightly regulated via interactions with other
proteins as well as by phosphorylation by a number of kinases.
Phosphorylation by p42/p44 MAPK, CDK2, protein kinase A,
and IKKa upregulate HAT activity [53,55] whereas phosphory-
lation by protein kinase Cd reduces HAT activity [56].
Transcriptional repressors also regulate gene expression.
General transcriptional repression occurs when a repressor
sequesters or modifies a member of the general transcriptional
machinery or PolII itself [57]. Expression of all genes transcribed
by PolII will then be inhibited. Gene-specific repression occurs
when a repressor targets a specific coactivator or interacts in a
promoter-specific manner with members of the general transcrip-
tional machinery or PolII. Therefore, only a subset of genes will be
inhibited.
Previously published data suggest that gene-specific repressors
may contribute to TLR2-initiated inhibition of transcriptional
responses to IFN-c [31]. The mycobacterial lipoprotein and TLR2
agonist LpqH induces expression of the transcription factor C/
EBPb, which can act as a transcriptional activator or repressor,
depending on the promoter and stimulus. This increased
expression correlated with inhibition of IFN-c-induced CIITA
transcription, and macrophages stimulated with LpqH and IFN-c
exhibited increased C/EBPb binding to the CIITA promoter. The
NOS2 promoter also has a C/EBPb binding site that is involved in
gene induction in response to TLR and IFN-c stimulation [58].
The CXCL11 promoter has two potential C/EBPb binding sites
from 252 to 244 (TGCCTGAAG) and from 224 to 216
(TCCTCAGAC), although the functionality of these sites remains
to be determined. It is therefore possible that C/EBPb or a related
protein may contribute to negative regulation of IFN-c-induction
of both CIITA and CXCL11. However, C/EBPb
2/2 macro-
phages were found to remain sensitive to LpqH-mediated
transcriptional inhibition of CIITA [31], suggesting that additional
factors are involved. One such factor may be C/EBPd, whose
expression is induced by TLR4 stimulation and has been shown to
regulate genes involved in the innate immune response as part of a
circuit with other transcription factors [59]. TLR2 stimulation also
induces C/EBPd expression and binding to the CIITA promoter
[31]. However, the potential inhibitory function of C/EBPd on
IFN-c-induced transcription needs to be explored.
We attempted to identify other potential transcription factor
binding sites that might be responsible for TLR2-mediated
inhibition by comparing the promoter sequences of several IFN-
c-inducible, Pam3CSK4-inhibited genes. Computer-based com-
parison of these promoter sequences with those from a control
group of unaffected, IFN-c-inducible genes did not yield an over-
represented transcription factor binding motif, indicating that
more than one signaling pathway is involved, or that inhibition is
mediated by one or proteins that do not bind promoter elements
directly (data not shown).
However, when specifically examining the CXCL11 and
CIITA promoters, we found that CXCL11 has an NF-kB binding
site at 268 to 259 (GGGGAATTCC) that is missing in CIITA.
Further investigation of the role of NF-kB in TLR2-mediated
inhibition of these genes using RelA
2/2 macrophages showed that
inhibition of CXCL11, but not CIITA, is NF-kB dependent
(Fig. 6). We could not detect binding of p65 or p50 to this site in
the CXCL11 promoter (data not shown), suggesting that NF-kB
most likely has an indirect inhibitory effect, possibly by inducing
expression of a protein that blocks CXCL11 transcription upon
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when new protein synthesis is blocked is concordant with this
mechanism (Fig. 3A).
We also examined potential epigenetic mechanisms as TLR2
stimulation has been shown to inhibit IFN-c-induced histone
acetylation at the promoters of genes involved in MHC class II
antigen presentation [25,43]. ChIP experiments done in murine
macrophages stimulated with LpqH followed by IFN-c showed
that acetylation of histones H3 and H4 was reduced at the CIITA
promoter compared to IFN-c stimulation alone [25]. This
inhibition was abrogated with pharmacological blockade of
MAPKs. In addition, this inhibition was partially reversed in the
presence of the HDAC inhibitor sodium butyrate, suggesting that
inhibition of histone acetylation is one mechanism by which TLR2
stimulation prevents CIITA expression.
We elaborated on those experiments to determine if inhibition
of histone acetylation was a common mechanism for TLR2-
mediated inhibition of other IFN-c-inducible genes. In contrast to
the inhibition of IFN-c-induced histone acetylation at the CIITA
promoter (Fig. 5B and E), histone acetylation at the CXCL11
promoter was unaffected by TLR2 stimulation (Fig. 5A and D).
Concordant with the transcriptional data, histone acetylation at
the NOS2 promoter increased with TLR2 stimulation (Fig. 5C
and F). This indicates that a decrease in modifications that make
the chromatin more accessible to transcription factors and
coactivators may be involved, but this is not the sole mechanism
responsible for TLR2-mediated inhibition of transcriptional
responses to IFN-c.
In contrast to the gene-selective requirement for NF-kB and
different effects of TLR2 stimulation on histone acetylation, we
found that TLR2 stimulation decreased IFN-c-induced binding of
RNA polymerase II at both the CIITA and CXCL11 promoters,
but not at the NOS2 promoter (Fig. 4A). This indicates that while
the intermediate signaling steps may vary for distinct genes, TLR2
stimulation interrupts a crucial step in transcription initiation at
specific IFN-c-responsive genes.
In addition to M. tuberculosis, other pathogens have developed
mechanisms to evade immune responses through disruption of
host gene transcription. The intracellular bacteria Listeria monocy-
togenes induces a reduction in total cellular histone acetylation early
after infection, mediated partially by listeriolysin O [60]. The
opportunistic pathogen Mycobacterium avium inhibits histone
acetylation at the HLA-DRa promoter, possibly through recruit-
ment of HDAC corepressor mSin3a, which was found to bind the
promoter following infection [43]. In those studies, infection also
led to a reduction in CBP recruitment to the HLA-DRa promoter.
Viruses also disrupt host gene transcription by preventing
transcriptional machinery assembly at gene promoters. Poliovirus
cleaves general transcription factors [61], Rift Valley Fever virus
blocks transcription factor assembly [62], and vesicular stomatitis
virus targets TBP using an unknown mechanism [63]. These all
prevent general PolII transcription. However, murine cytomega-
lovirus has been shown to inhibit specific gene transcription by
targeting IFN-c-inducible genes without affecting JAK/STAT
activation [64]. PolII binding to the promoters of the affected
genes was significantly reduced, suggesting that disruption of
transcriptional machinery assembly was responsible for this
inhibition.
The findings reported here extend the understanding of the
mechanisms that may be used by at least one pathogen,
Mycobacterium tuberculosis, to evade elimination by adaptive immune
responses. Developing the means to increase the efficacy of
adaptive immune responses in order to better control infection
with M. tuberculosis will require additional investigation; increasing
the efficacy of IFN-c by restoring macrophage transcriptional
responses to this cytokine may be one effective approach, but will
require further study.
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